Health
EHR data support reported effectiveness of Ad26.COV2.S vaccine – Medical Xpress
The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome…
The effectiveness of the Johnson & Johnson Ad26.COV2.S vaccine is 73.6 percent for preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, according to a study published online Nov. 2 in JAMA Network Open.
Juan Corchado-Garcia,…
Continue Reading
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General17 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay
-
Noosa News23 hours agoCat-Sitting Leads to Chaos for Austin Butler in the Trailer for Darren Aronofsky’s New Crime-Thriller ‘Caught Stealing’
-
Noosa News21 hours agoIs Auckland New Zealand’s New Cultural Capital?